Investors NYSE AMERICAN: LCTX Minimum 15 minutes delayed. Source: LSEG VIEW STOCK QUOTE Press Releases May 12, 2026 Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update May 05, 2026 Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026 May 04, 2026 OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026 VIEW PRESS RELEASES Events & Presentations OpRegen® 3 Year Clinical Data Update (Retinal Innovation Summit 2026) 2.1 MB Lineage Cell Therapeutics Corporate Overview (March 24, 2026) 4.9 MB Roche Pharma Day 2025 Presentation 8.1 MB First Quarter 2026 Financial Results Earnings Call May 12, 2026 at 4:30 PM EDT Click here for webcast VIEW EVENTS & PRESENTATIONS
May 12, 2026 Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 05, 2026 Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
May 04, 2026 OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026
First Quarter 2026 Financial Results Earnings Call May 12, 2026 at 4:30 PM EDT Click here for webcast
